Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
Jong Sung Park, Tae‐In Kam, Saebom Lee, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Deepali Singh
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 240
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 219
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 114
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Niklas Reich, Christian Hölscher
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 110
The impact of loneliness and social isolation on the development of cognitive decline and Alzheimer’s Disease
Yi Ren, Aisouda Savadlou, Soobin Park, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101061-101061
Open Access | Times Cited: 53
Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway
Akiko Nakano-Kobayashi, Andrés Canela, Toru Yoshihara, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 33
Open Access | Times Cited: 45
Immune Activation in Alzheimer Disease
Arnaud Mary, Renzo Mancuso, Michael T. Heneka
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 585-613
Closed Access | Times Cited: 19
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
Jeffrey L. Cummings, Alireza Atri, Howard Feldman, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du, Xiaoyu Meng, Yao Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 48
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9583-9583
Open Access | Times Cited: 41
Ultrastructural Remodeling of the Blood–Brain Barrier and Neurovascular Unit by Lipopolysaccharide-Induced Neuroinflammation
Michelle A. Erickson, T. V. Shulyatnikova, William A. Banks, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1640-1640
Open Access | Times Cited: 34
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
Maria Chiara Pelle, Isabella Zaffina, Federica Giofrè, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11301-11301
Open Access | Times Cited: 30
The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
Zi-han Li, Yayi Jiang, Caiyi Long, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 59-73
Open Access | Times Cited: 28
The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms
Sidhanth Chandra, Antonio Di Meco, Hemraj B. Dodiya, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 28
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Wenjun Cai, Tong Wu, Ning Chen
Biomolecules (2023) Vol. 13, Iss. 2, pp. 313-313
Open Access | Times Cited: 27
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease
Haleh Barmaki, Alireza Nourazarian, Fatemeh Khaki‐Khatibi
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 22
Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway
Xiaoxiao Shan, Wenwen Tao, Junying Li, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118145-118145
Closed Access | Times Cited: 11
Tryptophan Metabolism in Alzheimer’s Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis
Lushuang Xie, Qiaofeng Wu, Kelin Li, et al.
Aging and Disease (2024) Vol. 15, Iss. 5, pp. 2168-2168
Open Access | Times Cited: 11
Lycium Barbarum Polysaccharides Improves Cognitive Functions in ICV-STZ-Induced Alzheimer’s Disease Mice Model by Improving the Synaptic Structural Plasticity and Regulating IRS1/PI3K/AKT Signaling Pathway
Yingxi He, Yanyou Wang, Xia Li, et al.
NeuroMolecular Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 10
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Chien‐Tai Hong, Jia‐Hung Chen, Chaur‐Jong Hu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
Alberto Santiago-Balmaseda, Annai Aguirre-Orozco, Irais E. Valenzuela-Arzeta, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 921-921
Open Access | Times Cited: 9
Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
The Role of Microglia in the Development of Neurodegenerative Diseases
Jae‐Won Lee, Wanjoo Chun, Hee Jae Lee, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 42
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 162-177
Closed Access | Times Cited: 33
An emerging role of astrocytes in aging/neuroinflammation and gut-brain axis with consequences on sleep and sleep disorders
Sergey V. Gudkov, Dmitriy E. Burmistrov, Elena Kondakova, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101775-101775
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top